Individual Submission Summary
Share...

Direct link:

Maternal Brain Circuits for Empathic Sensitivity and Pain in Mothers with Opioid use Disorder

Fri, March 24, 3:30 to 5:00pm, Salt Palace Convention Center, Floor: 3, Meeting Room 355 E

Abstract

Background: Opioid-induced deficits in maternal behaviors are well-characterized in rodent models. Amid the current epidemic of opioid use disorder (OUD), prevalence among pregnant women has risen sharply. Despite gold standard buprenorphine-treatment (BT), affected mothers suffer withdrawal and major public health issues of postpartum depression, polysubstance use, relapse, and developmental risks to the infant. Using fMRI, we have developed a Maternal Behavior Neurocircuit (MBN) model, evolutionarily conserved to govern maternal caring and aggressive behaviors and critical to healthy child outcomes. In the MBN, the anterior cingulate gyrus (ACC) participates in mother-child bonding and attachment; and functions in an opioid sensitive “pain-matrix”. We have established that prescription opioids affect resting-state functional connectivity (rs-FC) between the dorsal ACC, rostral ACC, and other regions related to MBN in healthy participants without OUD. Allied literature suggests that prescription opioids may produce physical and emotional ‘analgesic’ effects by disrupting specific ACC-insula and ACC-putamen connectivity. However, even if acute use of opioids can reduce functional connectivity between these MBN-related regions, the effects of BT in mothers with chronic exposure of OUD remain unknown.
Methods: We studied 32 mothers with 6- minute resting state functional magnetic resonance imaging (rs-fMRI) at 1-month (T1) and 4-months postpartum (T2), including 7 on BT for OUD (BT/OUD, age: M = 29.86, SD = 6.62) and 25 non-OUD mothers as a comparison group (CG, age: M = 27.62, SD = 8.46). Region-of-interest spheres (10 mm) in the dACC and rACC that mediate analgesic effects were centered on MNI coordinates [0, 6, 40] and [0, 46, 2]. We restricted our analyses to insula and putamen, regions modulated by acute prescription opioid administration.
Results: We found significant time-by-group interaction effects in the rACC-dependent rs-FC with the left insula (MNI: [-40, 22, 2], 48 voxels, Z = 4.62, p = 0.003, family-wise error corrected) and the dACC-dependent rs-FC with the right putamen (MNI: [24, 16, -8], 169 voxels, Z = 5.17, p < 0.001, family-wise error corrected). BT mothers, as compared to CG mothers, showed less left insula-rACC rs-FC but greater right putamen-dACC rs-FC at T1, with these between-group differences reversed at T2.
Conclusions: This preliminary study pioneers the study of MBN and the pain-matrix activity among mothers receiving BT for OUD. This is particularly significant given the understudied potential beneficial and adverse effects of any exogenous opioids on maternal behavior. Previously, we have established that BT mothers differed from CG in periaqueductal grey-dependent rs-FC with the hypothalamus, amygdala, insular cortex, and other brain regions at T1, yet not at T2, suggesting potential therapeutic effects of continuing buprenorphine treatment, i.e., normalizing the background dysregulation of OUD. In the current study, we found time-by-treatment interaction effects on the dACC and rACC-dependent rs-FC – potentially identifying a brain mechanism for the benefits of BT on reversing dysfunction of maternal brain and behavior: the initial group differences in rs-FC flipped by four months postpartum. This work complements recent studies to ascertain how BT affects maternal behaviors, mother-child bonding, and intersubjectivity with MBN/pain-matrix targets for novel interventions.

Authors